|
 |
FDA Approval Activities for this Drug…
Sonata (zaleplon) CIV Capsules, Wyeth-Ayerst NDA 20-859/S2 & S3 5/31/02 6/3/02 Sonata (zaleplon) Capsule, 5 mg & 10 mg, Wyeth-Ayerst NDA 20-859/S1 2/22/01 3/5/01 3/5/01 Sonata (zaleplon) Capsule, Wyeth-Ayerst NDA 20-859 8/13/99 3/21/00 3/21/00 7/3/00 Sonata Indications: short-term treatment of insomnia ZALEPLON Capsule; 10MG SONATA JONES 020859 ZALEPLON Capsule; 5MG SONATA JONES
For the most up-to-date approval information, please locate this API using the drug index. |
|
|